RxDoctor Payments DataLook up a doctor →

Duncan Lahtinen, DO

Family Medicine · Spokane, WANPI 1407877491

Payments from drug & device makers

$25,172in general payments, 2019–2025

Across 1,484 payments — averaging $16.96 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Amgen$2K
  • AstraZeneca$2K
  • Pfizer$2K
  • Teva Pharmaceuticals USA, Inc.$2K
  • Johnson & Johnson$1K
  • plus $14K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)128$2,311
Amgen(2 entities)120$2,200
AstraZeneca107$2,016
Pfizer145$1,725
Teva Pharmaceuticals USA, Inc.79$1,670
Johnson & Johnson74$1,294
Boehringer Ingelheim71$1,263
Sekisui Diagnostics LLC4$1,180
GSK125$1,169
Novo Nordisk100$1,044
Salix Pharmaceuticals, A Division Of Bausch Health US, LLC59$1,000
Lilly USA, LLC56$787
Novartis30$574
Astellas Pharma US Inc29$540
Otsuka America Pharmaceutical, Inc.28$511
Exact Sciences26$459
Merck24$371
Abbott18$347
Corcept Therapeutics20$333
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)20$318
Lundbeck LLC16$278
Medtronic7$261
Bayer16$246
Sanofi-aventis U.S. LLC12$245
Amarin Pharma, Inc.15$235
Takeda Pharmaceuticals U.S.A., Inc.13$219
Vanda Pharmaceuticals Inc.11$198
Eisai Inc.7$138
Collegium Pharmaceutical, Inc.8$138
Grifols USA, LLC7$124
E.r. Squibb & Sons, L.L.C.7$123
Gilead6$106
Neurocrine Biosciences, Inc.6$105
Dexcom, Inc.5$99
BD2$92
Sumitomo Pharma America, Inc.5$90
Sanofi3$89
Xeris Pharmaceuticals, Inc.4$77
Viiv Healthcare Company2$73
Hologic Sales And Service, LLC4$72
Antares Pharma, Inc.5$68
Avanir Pharmaceuticals, Inc.4$67
Boston Scientific2$66
Radius Health, Inc.4$61
Kyowa Kirin, Inc.2$57
Kowa Pharmaceuticals America, Inc.4$57
Phathom Pharmaceuticals, Inc.6$56
Supernus Pharmaceuticals, Inc.3$46
Paratek Pharmaceuticals, Inc.3$45
Genentech USA, Inc.2$43
United Therapeutics Corporation2$39
Sanofi Pasteur Inc.2$38
Sunovion Pharmaceuticals Inc.3$37
Edwards Lifesciences2$37
Nevro Corp.1$34
Upsher-smith Laboratories LLC2$33
Phadia US Inc.2$31
Axsome Therapeutics, Inc.2$31
Almatica Pharma LLC2$26
Biohaven Pharmaceuticals, Inc.1$24

How this compares

$25,172 in reported general payments places this provider in the 95th percentile of 2,275 family medicine providers in Washington.

See all family medicine providers in Washington →

Medicare billing

Part B allowed, 2024
$116,895
Medicare patients
283
Services billed
1,966

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other family medicine in Spokane

See the full list for Washington →

Where these figures come from

Is this you, or does something look wrong? →